Genmab A/S ADR (GMAB): Price and Financial Metrics
GMAB Price/Volume Stats
| Current price | $20.27 | 52-week high | $30.41 |
| Prev. close | $20.07 | 52-week low | $17.24 |
| Day low | $19.68 | Volume | 1,791,000 |
| Day high | $20.28 | Avg. volume | 1,555,415 |
| 50-day MA | $20.54 | Dividend yield | N/A |
| 200-day MA | $22.93 | Market Cap | 13.41B |
GMAB Stock Price Chart Interactive Chart >
Genmab A/S ADR (GMAB) Company Bio
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark - internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan. It's a dual listed company with shares traded on the Copenhagen Stock Exchange in Denmark, and on NASDAQ Global Select Market in the US. (Source:Wikipedia)
GMAB Price Returns
| 1-mo | 5.08% |
| 3-mo | -4.79% |
| 6-mo | -12.33% |
| 1-year | -29.03% |
| 3-year | -44.40% |
| 5-year | -15.54% |
| YTD | -2.87% |
| 2024 | -34.45% |
| 2023 | -24.87% |
| 2022 | 7.13% |
| 2021 | -2.71% |
| 2020 | 82.09% |
Loading social stream, please wait...